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A B S T R A C T
The coronavirus (CoV) family consists of viruses that infects a variety of animals including humans with various
levels of respiratory and fecal-oral transmission levels depending on the behavior of the viruses' natural hosts
and optimal viral fitness. A model to classify and predict the levels of respective respiratory and fecal-oral
transmission potentials of the various viruses was built before the outbreak of MERS-CoV using AI and em-
pirically-based molecular tools to predict the disorder level of proteins. Using the percentages of intrinsic dis-
order (PID) of the nucleocapsid (N) and membrane (M) proteins of CoV, the model easily clustered the viruses
into three groups with the SARS-CoV (M PID= 8%, N PID = 50%) falling into Category B, in which viruses have
intermediate levels of both respiratory and fecal-oral transmission potentials. Later, MERS-CoV (M PID = 9%, N
PID = 44%) was found to be in Category C, which consists of viruses with lower respiratory transmission
potential but with higher fecal-oral transmission capabilities. Based on the peculiarities of disorder distribution,
the SARS-CoV-2 (M PID = 6%, N PID = 48%) has to be placed in Category B. Our data show however, that the
SARS-CoV-2 is very strange with one of the hardest protective outer shell, (M PID = 6%) among coronaviruses.
This means that it might be expected to be highly resilient in saliva or other body fluids and outside the body. An
infected body is likelier to shed greater numbers of viral particles since the latter is more resistant to anti-
microbial enzymes in body fluids. These particles are also likelier to remain active longer. These factors could
account for the greater contagiousness of the SARS-CoV-2 and have implications for efforts to prevent its spread.
1. Introduction
In December of 2019, a mysterious virus that causes pneumonia and
produces pneumonia-like symptoms; i.e., dry cough and fever was no-
ticed to be spreading in Wuhan, Hubei Province, China [1–4]. The
culprit was quickly identified as a new respiratory coronavirus (CoV).
This virus and its disease are currently known as Severe Acute Re-
spiratory Syndrome coronavirus-2 (SARS-CoV-2 and coronavirus in-
fectious disease 2019 (COVID-19) respectively [1–4]. SARS-CoV-2 is
observed to be even more contagious (but fortunately less fatal) than
SARS-CoV that was seen in 2003.
In 2011–2012, just before the outbreak of the Middle Eastern
Respiratory Syndrome (MERS-CoV), we built an empirically-based
model that measures the percentage of intrinsic disorder (PID) of the
membrane (M) and nucleocapsid (N) proteins in viruses [5,6]. The main
tool uses AI technology to recognize intrinsic disorder, given the protein
sequence. The model involves the listing of shell disorder by cor-
onaviruses that is easily clustered into three groups, which incidentally
correlate with the known levels of fecal-oral and respiratory transmis-
sion of the various coronaviruses. The model predicts that the 2003
SARS-CoV (M PID = 8% and N PID = 50%) is included into a category
of CoVs with intermediate levels of both respiratory and fecal-oral
transmission potentials.
An opportunity to test the validity of this model came when MERS-
CoV first struck the Middle East in 2012. Upon the availability of the
sequences of both MERS-CoV M and N proteins, the authors were able
to confirm that MERS-CoV falls solidly into a category of viruses that
have lesser respiratory transmission potential but have greater fecal-
oral transmission capabilitie [6,7]. The categorization of MERS-CoV
within this category was supported by the observations that MERS-CoV
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is not efficiently spreading among humans, unlike SARS-CoV, and re-
quires close contact [8]. Furthermore, it is now known that camels are
the natural reservoir for MERS-CoV, and viruses that are associated
with farm animals, such as camels, tend to have greater fecal-oral
transmission potentials [9].
In this study, we will have the opportunity to once again test the
model. This time, it will involve the SARS-CoV-2. We shall see that not
only the model is reliable and consistent, but is able to detect something
very odd about this virus that could account for its quick spread.
2. Methods
2.1. Protein intrinsic disorder predisposition and PONDR® VLXT
Protein intrinsic disorder is found when portions of or an entire
protein has no structure. It is also called by other names such as un-
structured, natively unfolded [10–12]. The main tool used to develop
the CoVs shell disorder model involves the use of neural networks that
had been trained to recognize ordered and disordered regions of a
protein given its sequence. A suite of such artificial intelligence tools
(AI) have been named PONDR® (http://www.pondr.com).
Of a particular interest. PONDR® VLXT has been found to be accu-
rate for structural proteins with protein-protein and protein-RNA/DNA
interactions [13–17]. In fact, PONDR® VLXT has shown consistency and
reproducibility when used for the study of structural viral shells that
protect the virion from environmental damage. A wide range of viruses
have been studied using PONDR® VLXT including equine infectious
anemia virus (EIAV), human immunodeficiency virus (HIV), herpes
simplex virus (HSV), smallpox virus, polio virus, Nipah and Ebola
viruses, SARS-CoV, MERS-CoV, influenza virus, hepatitis C virus (HCV),
hepatitis A virus (HAV), yellow fever virus (YFV), and Zika virus
[2,5–7,18–27].
2.2. M and N proteins
The coronavirus virion contains four major structural proteins: the
spike (S) protein, nucleocapsid (N) protein, membrane (M) protein, and
the envelope (E) protein [5–7,28–30]. These proteins are needed for
production of a structurally complete viral particle [30–33]. The main
focus of our intrinsic disorder-based model is at the viral M and N
proteins. The M protein of CoV was chosen over the E protein because
the M protein is a major transmembrane protein that is found in large
numbers in the virion, whereas E protein is a minor protein of the en-
velope. Also, in previous studies, membrane or matrix proteins of var-
ious viruses were analysed with respect to their intrinsic disorder
content and roles in protecting the respective virions. The N protein is
also important for our model, as it has been shown that greater disorder
in the inner shell is associated with the mode of infection and virulence
in other viruses [23–26].
2.3. Disorder and statistical analyses
The protein sequences of the selected CoV M and N proteins were
downloaded from UniProt (http://www.uniprot.org) The sequences
were fed into a MYSQL database using JAVA [19]. The sequences were
fed into the PONDR® VLXT, and the corresponding results were ar-
chived in the database. PONDR® VLXT provides intrinsic disorder pre-
disposition scores for each residue. Residues with the scores of 0.5 and
above are considered disordered, and, conversely, residues with the
scores below 0.5 are taken as ordered. We represented the outputs of
these analyses in the form of the percentage of intrinsic disorder (PID),
which is defined as the number of residues predicted to be disordered
divided by the total number of residues in a query protein. Statistical
analyses using regression analysis and Analysis of Variance (ANOVA)
were done using R statistical package [34]. Regression analyses were
done using category as the dependent variable with M and N PIDs as
independent variables or N PID as a sole independent variable. Cate-
gories were assigned the values of 1, 2 and 3 to the three groups as
according to the level of respiratory transmission potential. The amino
acid sequences of the SARS-CoV-2 M and N proteins are available at
NCBI (https://www.ncbi.nlm.nih.gov/nuccore/MN908947).
Table 1
Categorization of coronaviruses by shell disorder to predict levels of Respiratory and Fecal-oral transmission (Statistical Analyses:Two-Way ANOVA, p < 0.00),
(Regression analysis of category as dependent variable with M and N PIDs as independent variables: p < 0.001, r2 = 0.83, Regression analysis with only N PID as an
independent variable: p < 001, r2 = 0.77).
Shell
Disorder Category
Coronavirus M PID % (UniProt/Genbank Accession
Code)a
N PID % (UniProt/Genbank Accession Code)b Remarks
A HCoV-229E 23(P15422) 56(P15130) Higher Levels of Respiratory Transmission
Lower Levels of Fecal-oral TransmissionIBV(Avian) 10(P69606) 56(Q8JMI6)
B Bovine 7.4(P69704) 53(Q8V432) Intermediate Levels of Respiratory and
Fecal-oral
Transmission
PEDV(Porcine) 8(P59771) 51(Q07499)
Canine(Resp.) 6.5(A3EXD6) 51(A3E2F7)
HCoV-OC43 7(Q4VID2) 51(P33469)
SARS-CoV 8(P59596) 50(P59595)
HCoV-NL63 11(Q6Q1R9) 49(Q6Q1R8)
Bat-HKU4 16(A3EXA0) 48(A3EXA1)
**SARS-Cov-2**c 6(QHD43419.1)d 48(QHD43423.2)d
Bats 11.5(A3EXD6) 47(Q3LZX4)
Bat-HKU5 11(A3EXD6) 47(A3EXD7)b
C MHV(Murine) 8(Q9JEB4) 46(Po3416) Lower Levels of Respiratory Transmission
Higher Levels of Fecal-oral TransmissionMERS-CoV 9(K0BU37) 44(K0BVN3)
TGEV(Porcine) 14(P09175) 43(P04134)
Canine(Ent.) 8(B8RIR2) 40(Q04700)
HCoV-HKU1 4(Q14EA7) 37(Q0ZME3)
a M PID refers to the percentage of intrinsic disorder (PID) of the membrane protein (M). PID is measured by the number of residues predicted to be disordered
divided by the total number of disorder. M PID predicts how long the virus can remain outside the body. M is considered to be one of the outer shell.
b N protein refers to the nucleocapsid protein, which is an inner shell protein.
c SARS-CoV-2 (COVID).
d Genbank accession code, https://www.ncbi.nlm.nih.gov/nuccore/MN908947.
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3. Results
3.1. Statistical analysis indicates clustering of CoVs into three statistically
identifiable categories
As aforementioned, the model predicting the mode of viral trans-
mission was built before the 2012 MERS-CoV outbreak. This model was
based on the analysis of mainly the PIDs found for N proteins, the
viruses were clustered into three groups according to their transmission
mode, while the M PIDs provide an indicator of resilience of the virus in
the harsh environment. The three groups are represented in Table 1. A
Two-Way ANOVA (p < 0.001) indicates that the groups are statisti-
cally identifiable. The Table shows that category A consists of viruses
that have greater respiratory transmission capabilities but lower fecal-
oral transmission potentials. Category B involves coronaviruses that
have intermediate levels of both respiratory and fecal-oral transmission
potentials, whereas category C comprises of viruses with lower re-
spiratory transmission. Furthermore, a higher inner shell disorder is
often associated with the greater infectivity, especially with regard to
respiratory transmission potential since disorder allows greater pro-
miscuity of binding [6,7].
3.2. SARS-CoV-2 is in the category of CoVs with intermediate fecal-oral and
respiratory transmission potentials
Table 1 shows that SARS-CoV is grouped into category B along with
other viruses that have intermediate respiratory and fecal-oral trans-
mission potentials. MERS-CoV falls into category C (lower respiratory
potential but higher fecal-oral transmission capabilities). These are
consistent with what we know about transmission behaviour of SARS-
CoV and MERS-CoV [5–8,35]. It should be noted that category A are
viruses with N PID above 53%, whereas category C comprises of those
with N PID below 47%. Since SARS-CoV-2 has an N PID of 48%, which
is above 46% but below 54%, it must be considered as being in category
B.
3.3. SARS-CoV-2 has one of the hardest outer shell among CoVs (M
PID = 6%)
As already mentioned, based on the similar analysis of the SARS-
CoV-2 (M PID = 6%, N PID = 48%), it is clear that this virus has to be
placed in Category B, along with SARS-CoV (Table 1). However, our
data also pointed to something odd about the SARS-CoV-2. In fact,
Table 1 and Fig. 1 show that data for the SARS-CoV-2, the M PID is 6%,
which is second lowest in our sample of a fairly diverse selection of
CoVs. This means that the SARS CoV-2 has one of the hardest outer
shells among its counterparts.
3.4. Disorder and statistical analyses
The model is consistent with the theme that viruses that remain in
harsh environments require harder; i.e., less disordered, shells to sur-
vive. Furthermore, the outer shell is likely to play an even greater role
in protecting the virion [20,22,27]. This has important implications
pertaining to the characteristics and behaviors of the virus as we shall
see below.
4. Discussion
4.1. Evidence of consistency and reproducibility
A superficial glance at the model that places SARS-CoV and SARS-
CoV-2 in the same category, with intermediate levels of respiratory
transmission potentials may mislead the reader to believe that the
model is not reliable, given the fact that we have now seen that SARS-
CoV-2 is much more contagious than SARS-CoV. We believe that this is
not the case. If SARS-CoV-2 would be placed in category C, the same
category as MERS-CoV, then the model would be definitely wrong in
terms of reproducibility. On the other hand, the placing of SARS-COV-2
in category A would be an inconsistency that would be difficult to ex-
plain. One would further notice that very few CoVs fall into category A,
with the exception for HCoV-229E and infectious bronchitis virus (IBV),
which make the chance of any CoVs including SARS-COV-2, to be in
category A slim. More importantly, because SARS-CoV-2 is zoonotic and
the only non-human CoV in category A is the avian IBV, placing SARS-
COV-2 in category A could suggest that this virus is likely to be of avian
origin, which is inconsistent with what we know about SARS-CoV-2.
Phylogenetic study has confirmed that the closest relatives of SARS-
CoV-2 are bat CoVs [4,36]. We also noticed that at least three of closest
neighbors with similar N PIDs of 47–48% are those of bat origin (See
Table 1). This suggests that bat CoVs are likely to have an optimal mix
of fecal-oral and respiratory transmission potentials that reflect their N
PID range of 47–48%, which provides for greater fitness for the spread
of the viruses among bats and that SARS-CoV-2 is likely to be of bat
origin too given its N PID is 48%. There are highly debatable sugges-
tions that snakes or pangolins [3,37,38] may be an intermediary host of
the virus. Even if any of these is later deemed as true, our data imply
that the virus had not the chance to evolved much with any inter-
mediary host except bats, unlike the cases of SARS-CoV and MERS-CoV,
in which the model does suggest that they had evolved with hosts such
Fig. 1. Level of disorder (PID ie Percentage of Intrinsic Disorder) for the M protein. M PID for SARS-CoV-2 (**) is among the lowest in its family, which is indicative of
its hard outer shell.
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as civet cats and camels respectively. This suggestion is, however, based
on N PID alone.
4.2. Evidence of correlations between modes of transmission and shell
disorder
The CoV shell disorder model was originally conceived as part of a
spin-off from a parent research project that studied relationships among
the mode of transmission, shell disorder and the absence of vaccines for
certain sexually transmitted viruses such as HIV, HSV and HCV
[19,20,27]. At that time even after 2003 SARS-CoV, the wealth of CoV
knowledge lies in the field of veterinary medicine [5,6]. Using what was
then known about behaviors of porcine CoVs, a successful attempt to
correlate M and N PIDs to modes of transmission was made [5,6]. The
results were similar to those found in Table 1 and Fig. 1 without the
data pertaining to MERS-CoV and SARS-CoV-2, of course, since the
MERS-CoV and COVID-19 outbreaks had yet to occur then.
Evidence of a strong correlation of M and N PIDs to the mode of
transmission (r2 = 0.83, p < 0.001) can be seen in the regression
analysis. Furthermore, a strong but oddly weaker correlation
(r2 = 0.77, p < 0.001) can also be found when N PID is the sole
independent variable even if poor correlation (r2 = 0.21) is found when
M PID is the sole independent variable. This basically means that the
model should include both M and N PIDs as the statistical model seems
to suggest that M PID does contribute, even if slightly, to the mode of
transmission in conjunction to the major contribution by N PID. .This is
consistent with the idea that both M and N play roles in protecting the
virion from environmental damage and the need to protect the virion is
dependent on mode of transmission. A qualitative inspection of the
viruses in the three groups also reveals consistency. For example, as in
Table 1, canine CoV-respiratory falls into category B, while canine CoV-
enteritis is in category C. The porcine CoVs are also consistent with
observation of their behaviors as we will later see.
We need to keep in mind, however, that the outer shell is likely to
play a greater and more immediate role in protecting the virion from
environmental damage as it encases the entire virion, whereas the N
protein is likely to protect only the RNA. M PID is therefore a more
crucial indicator of the “hardness” of the virion. However, because of
the higher correlation of N to the mode of transmission, our model is
apparently suggesting that some other mechanisms are involved. In
fact, studies of inner shell of other viruses such as Nipah virus, Ebola
virus and flaviviruses [23–26] have indicated strong correlations be-
tween inner shell disorder and virulence. In the case of Nipah virus, the
virulence and inner shell disorder were linked to the modes of trans-
mission [26].
4.3. Greater viral loads in body fluids may be necessary for respiratory
transmission: Roles of N disorder and protein binding promiscuity
The mechanism in which the virus acquires greater virulence via
inner shell disorder arises from the ability of the viral protein to bind
promiscuously to the host protein [6,23–26]. This ability provides for
rapid replication of the viral proteins and particles. This quick re-
plication is also an efficient way to evade the host immune system by
reproducing a large number of viral particles before the immune system
even recognizes the virus, which then often goes on to overwhelm the
body leading to the death of the host [6,23–26]. One highly plausible
explanation for the link between rapid replication and the modes of
transmission is that viral load in the body fluids of the infected host
needs to be sufficiently high before the virus can be infectious via the
respiratory mode. This therefore explains the fact that rapid viral re-
plication and inner shell disorder were found to be the common link
between virulence and respiratory transmission in the case of Nipah
virus [26].
We don't, however, know if there is correlation between CoV viru-
lence and inner shell disorder, even though the authors believe it exists,
just like the other viruses. If so, N will make an excellent target for CoV
vaccine development.The difficulty in the search for such links is that
CoVs infect a large variety of animals and each CoV often uses a dif-
ferent receptor [4,6,39]. For example, MERS-CoV has a case-fatality
rate of above 30% [8] for humans but is generally harmless to camels
[27]. Furthermore, CoVs were generally not known to be virulent be-
fore the 2003 SARS-CoV outbreak and therefore lack adequate data for
us to work with.
The reason that we can make the necessary above-mentioned ex-
trapolations pertaining to inner shell disorder among unrelated viruses
with somewhat greater confidence is that inner shell proteins of dif-
ferent species of viruses often share similar functions and structures
[30,40,41]. For example, the CoV N proteins, like the nucleocapsids in
other viruses, are responsible for assembling viral particles by forming
complexes with other viral proteins and RNA [24,25,41]. The N protein
also helps with the packaging and budding of viral particles in the host
ER (Endoplasmic Reticulum) [23,30,40]. Such tasks require binding to
host proteins, and the promiscuous protein binding capabilities of a
more disordered N will certainly help towards rapid replication of the
virus.
4.4. Hard outer shell might contribute to the high contagiousness of SARS-
CoV-2
Since both SARS-CoV and SARS-CoV-2 have intermediate re-
spiratory transmission potentials, how do we account for the greater
contagiousness of the latter? We need to understand that the respiratory
transmission potential of a single viral particle is just one of several
factors that might contribute to the contagiousness of the virus. Other
factors include how many particles are released by the host and how
long does the particle remain in the environment. We mentioned that
our model has detected something odd about SARS-COV-2: this virus
has one of the hardest outer shell within the family as seen in Fig. 1 and
Table 1 (M PID = 6%). Since the outer shell plays the greater role in
protecting the virion in comparison to the inner shell, the harder outer
shell provides virus greater resilience to outside the body environment
and to the presence of digestive enzymes found in the saliva, mucus,
and other bodily fluids [20,22,42–46]. As a result, the virus with the
harder outer shell is able to remain active for a longer time and,
therefore a lesser number of viral particles is required for a chance to
infect someone. Furthermore, because the virus is more resistant to the
digestive enzymes in the bodily fluids, an infected body is likely to
discharged more infectious particles.
Evidence of the protective role of the outer shells be seen in a wide
variety of viruses. Viruses associated with saliva (e.g., YFV, ZIKV, EIAV,
rabies) or fecal-oral transmission (e.g., poliovirus), have hard outer
shells with low PID, whereas sexually transmitted viruses (e.g., HIV,
HSV-2, HCV) have higher outer shell PIDs [6,20–27]. Also, viruses that
are notorious for lasting in the environment for a long time such, as the
smallpox virus, have low outer shell PIDs.
4.5. Lessons from the porcine cousins: PEDV vs. TGEV
Before the SARS-CoV outbreak, coronaviruses were not considered
medically important, as, in the past, they had been primarily associated
with cold viruses that cause minor sniffles. This is, however, not true in
the field of veterinary medicine, where coronaviruses have posed a
menace to livestock. This is especially so in the case of TGEV (trans-
missible gastroenteritis virus) and PEDV (porcine epidemic diarrhea
virus). TGEV could move rapidly among farm pigs to quickly devastate
the farming community if not controlled early [5–7]. Our analysis re-
veals that TGEV is of category C (higher fecal-oral, lower respiratory
transmission potentials) with M and N PIDs at 14% and 43% respec-
tively. The reason that it is able to move rapidly is that its high fecal-
oral transmission potential represents a more efficient mode of trans-
mission among the farm animals.
G.K.-M. Goh, et al. Microbial Pathogenesis 144 (2020) 104177
4
There is an antigenically related cousin, PEDV, which has similar
characteristics as TGEV [29]. Like TGEV, diarrhea and vomiting are
main symptoms of PEDV infection. While TGEV is highly infectious,
PEDV is less contagious among farm pigs. A peculiar characteristic has
been observed by farmers and veterinarians: PEDV can reappear out of
nowhere from within the same pen that was previously occupied by
infected pigs, even after the disease has passed on several months ago.
An inspection of the M and N PIDs reveals the reason showing that
PEDV belongs to the category B, along with SARS-CoV and SARS-CoV-2,
unlike TGEV and MERS-CoV. This means that PEDV has a higher re-
spiratory transmission potential than TGEV and that implies greater
chances of fecal-respiratory transmission for the former. Obviously,
viral particles in fecal materials that was somehow inadvertently left
behind go on to infect a new population of pigs several months later
[5–7].
4.6. Airborne virus from feces, mucus, vomit and saliva: A hidden foe
Infectious droplets from mucus, vomit, or feces have actually been
seen during the SARS-CoV outbreak. A stark example happened in a
2003 outbreak at Amoy Gardens, a housing complex in Hong Kong,
where a huge cluster of infected patients was found and the inefficient
sewerage and toilet ventilation systems were responsible for the spread
[5,35,47]. We need to be reminded that PEDV, SARS-CoV, and SARS-
CoV-2 are all under the same category B, and that SARS-CoV-2 has the
hardest outer shell within the entire CoV family.SARS-CoV-2 is thus
likely to be able remain infectious in the environment for the longest
time regardless of being in feces, mucus, vomit, sweat, or saliva.
4.7. Evidence of advantage of greater resilience in the environment: PEDV
A puzzling thing can be observed is when we notice that PEDV (M
PID = 8%) has a harder outer shell than TGEV (M PID = 14%), given
that TGEV is predicted as having higher fecal-oral transmission poten-
tial. We would think that having greater fecal-oral potential requires
harder outer shell among CoVs. Apparently, the result is implying that
this is not necessarily true, as we have seen, and having higher fecal-
oral transmission potential can actually provide greater efficiency in the
spread among farm animals, as we have seen in TGEV, such that the
virus does not have to stay long outside the body. The ability to stay
longer in the environment could, however, provide advantages to a
virus with greater respiratory transmission potential, especially with
respect to spread via airborne virus from feces or body fluids. This is
likely the case for SARS-CoV-2.
5. Conclusion
We have presented here a set of data that not only place the SARS-
CoV-2 within the category of CoVs that have intermediate levels of both
respiratory and fecal-oral transmission potentials, alongside SARS-CoV
and PEDV, but have also predicted SARS-CoV-2 to have one of the
hardest outer shells among most CoVs. This peculiarity is likely re-
sponsible for its high level of contagiousness, since hardness of its outer
shell could provide the virus with the greater resilience to the condi-
tions outside the body and in body fluid, as the harder shell will better
protect the virion from damage as a result of the hostile environment
and action of the digestive enzymes found in bodily fluids. As a result, it
is likely that the infected body can shed more infectious particles that
have a greater chance of infecting a person over its lifetime. Chances of
infections via indirect contact and airborne virus from feces and bodily
fluids are therefore greater. The results of our research could have
important implications for epidemiologists and public health officials.
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